Reagents and supplies

Ended Awarded Last action

Contract number
HT001422F0061
Awardee
Awarding agency
Obligated
$1,534,293

Award facts

Contract value 100% obligated
$1,534,292.82 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
622110 General Medical and Surgical Hospitals
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $1,534,292.82 firm fixed price blanket purchase agreement (BPA) call contract to provide reagents and supplies. The contract has a period of performance from January 21, 2022 through July 1, 2022 and will be performed in Bethesda, Maryland. Roche Diagnostics Corporation will serve as the prime contractor to supply laboratory reagents and consumable materials to the Defense Health Agency in support of their medical testing requirements.

Quick answers

Who was awarded contract HT001422F0061?

HT001422F0061 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on January 21, 2022.

How much is contract HT001422F0061 worth?

The government has obligated $1,534,293 on HT001422F0061.

Is contract HT001422F0061 an order under another contract?

Yes. HT001422F0061 is a BPA call under HT001421A0001, a blanket purchase agreement.

Was contract HT001422F0061 competed?

The extent of competition for HT001422F0061 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award